ESC 2018: Use of SGLT2 inhibitors in clinical practice to reduce CV mortality in patients with type 2 diabetes - Prof Javed Butler & Prof Stefan Anker

 

Prof Javed Butler (Stony Brook University Hospital, New York, US) and Prof Stefan Anker (Charité Campus Virchow-Klinikum, Berlin, DE) discuss the use of SGLT2 inhibitors in clinical practice to reduce CV mortality in patients with type 2 diabetes.

Filmed on-site at ESC 2018 by Radcliffe Cardiology.